Please login to the form below

Not currently logged in
Email:
Password:

brain cancer

This page shows the latest brain cancer news and features for those working in and with pharma, biotech and healthcare.

UK approval for Seagen’s oral HER2 inhibitor Tukysa

UK approval for Seagen’s oral HER2 inhibitor Tukysa

patients whose cancer had metastasised into the brain at the time they were enrolled in the study. ... The Tukysa combination is a landmark therapy for patients with HER2-positive metastatic breast cancer with or without brain metastases, extending

Latest news

More from news
Approximately 1 fully matching, plus 79 partially matching documents found.

Latest Intelligence

  • Cancer care – the power of new technologies Cancer care – the power of new technologies

    on the tumour type that they had, with brain cancer patients highlighting a significantly worse experience than for other tumour types. ... As people are living longer, more and more people will be living longer with cancer.

  • Deal Watch January 2018

    enhance blood-brain barrier (BBB) penetration of antibody molecules via the transferrin receptor. ... that is highly selective for HER2.  Tucatinib is currently being evaluated in a phase II pivotal trial in patients with HER2-positive metastatic

  • Sharing ideas to improve care for cancer patients – part 2 Sharing ideas to improve care for cancer patients – part 2

    Taking place on September, 4 at 1pm, the free, one-hour webinar will feature speakers from Bristol Testicular Cancer Service, Mount Vernon Cancer Centre and The Brain Tumour Charity. ... Theresa Sullivan, Macmillan Patient Information Lead, Mount Vernon

  • Sharing ideas to improve care for cancer patients – part 1 Sharing ideas to improve care for cancer patients – part 1

    from Bristol Testicular Cancer Service, Mount Vernon Cancer Centre and The Brain Tumour Charity. ... Title: Shout Out! magazine for 7-13 year olds with living with cancer.

  • Interview: Michel Goldman, Innovative Medicines Initiative Interview: Michel Goldman, Innovative Medicines Initiative

    And we do this by implementing proposals in different areas. For example, we have several projects on brain disorders, diabetes, cancer, inflammatory disorders and several projects on pulmonary diseases, to give

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics